Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial (Q34647153)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial |
scientific article |
Statements
1 reference
Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial (English)
1 reference
Kiat Ruxrungtham
1 reference
José Valdez Madruga
1 reference
Daniel Berger
1 reference
Marilyn McMurchie
1 reference
Fredy Suter
1 reference
Denes Banhegyi
1 reference
Dorece Norris
1 reference
Eric Lefebvre
1 reference
Marie-Pierre de Béthune
1 reference
Frank Tomaka
1 reference
Martine De Pauw
1 reference
Tony Vangeneugden
1 reference
Sabrina Spinosa-Guzman
1 reference
TITAN study group
1 reference
1 July 2007
1 reference
1 reference
370
1 reference
9581
1 reference
49-58
1 reference
Identifiers
1 reference
1 reference